High Point, N.C.-based Banner Pharmacaps is pushing the encapsulation envelope with veggie-based and anti-counterfeiting products, but manufacturing challenges abound, explains Aqeel Fatmi, Ph.D., global VP of R&D, in this exclusive Q&A.
R.J. Reynolds spinoff Targacept is the leader in using nicotinic compounds for therapeutic benefit. Bill Caldwell, VP of drug discovery and development, tells why and shares tech transfer secrets in this exclusive audio interview.
The Sarbanes-Oxley Act has added a wrinkle to whistleblower protections first outlined in 1989. This exhaustive
research by Harvard third-year law student John Rouse outlines protections for FDA and private-sector pharmaceutical employees, with a special look at the implications of Dr. David Grahams criticism of FDAs oversight of Vioxx.